NetworkNewsBreaks – Redfund Capital Corp.’s (C
Post# of 36

Redfund Capital (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) this morning announced that Biolog Inc., a portfolio client of the company, has partnered with Cannabis Strategic Ventures (OTC: NUGS) to develop water-soluble cannabis technologies intended to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products. Per the agreement, Biolog will develop the new technologies with NUGS and the companies will work together regarding marketing to bring the products to market. “Working alongside Cannabis Strategic Ventures and assisting them to realize their mandate building their products brands using Biolog technology shows collaboration of incubators in the space. Branded products are the niche we believe will lead the industry just as patented medical products lead pharma for many decades. Biolog’s licensing agreements with Lexaria makes them a leader of the medical cannabis pack. This client in our portfolio looks to be our next go-public prodigy,” Redfund CEO Meris Kott stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

